1. Home
  2. GRFS vs HOMB Comparison

GRFS vs HOMB Comparison

Compare GRFS & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • HOMB
  • Stock Information
  • Founded
  • GRFS 1940
  • HOMB 1998
  • Country
  • GRFS Spain
  • HOMB United States
  • Employees
  • GRFS N/A
  • HOMB N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • HOMB Major Banks
  • Sector
  • GRFS Health Care
  • HOMB Finance
  • Exchange
  • GRFS Nasdaq
  • HOMB Nasdaq
  • Market Cap
  • GRFS 6.2B
  • HOMB 5.8B
  • IPO Year
  • GRFS 2006
  • HOMB 2006
  • Fundamental
  • Price
  • GRFS $10.10
  • HOMB $28.66
  • Analyst Decision
  • GRFS Hold
  • HOMB Hold
  • Analyst Count
  • GRFS 1
  • HOMB 5
  • Target Price
  • GRFS $10.30
  • HOMB $31.80
  • AVG Volume (30 Days)
  • GRFS 1.1M
  • HOMB 1.2M
  • Earning Date
  • GRFS 01-01-0001
  • HOMB 07-16-2025
  • Dividend Yield
  • GRFS N/A
  • HOMB 2.79%
  • EPS Growth
  • GRFS N/A
  • HOMB 14.00
  • EPS
  • GRFS 0.31
  • HOMB 2.19
  • Revenue
  • GRFS $7,968,532,207.00
  • HOMB $1,008,649,000.00
  • Revenue This Year
  • GRFS $7.14
  • HOMB $11.25
  • Revenue Next Year
  • GRFS $7.16
  • HOMB $2.78
  • P/E Ratio
  • GRFS $41.40
  • HOMB $13.11
  • Revenue Growth
  • GRFS 10.76
  • HOMB 3.77
  • 52 Week Low
  • GRFS $6.19
  • HOMB $24.22
  • 52 Week High
  • GRFS $10.30
  • HOMB $32.91
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 67.23
  • HOMB 45.93
  • Support Level
  • GRFS $9.66
  • HOMB $28.07
  • Resistance Level
  • GRFS $10.30
  • HOMB $30.42
  • Average True Range (ATR)
  • GRFS 0.26
  • HOMB 0.61
  • MACD
  • GRFS 0.00
  • HOMB -0.09
  • Stochastic Oscillator
  • GRFS 85.19
  • HOMB 25.11

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

Share on Social Networks: